Improving care for depression in patients with comorbid substance misuse.

OBJECTIVE The authors investigated whether quality improvement programs for depression would be effective among substance misusers and whether there would be a differential program-by-comorbidity effect. METHOD A group-level randomized controlled trial (Partners in Care) compared two quality improvement programs for depression with usual care. Consecutive patients (N=27,332) from six managed care organizations in five states were screened, and 1,356 were enrolled: 443 received usual care while the rest entered a quality improvement program involving either medication (N=424) or therapy (N=489). Multiple logistic regression was used to test hypotheses and compute standardized predictions of the adjusted rates of depression and use of psychotherapy and antidepressants. RESULTS Under usual care conditions, depressed patients with substance misuse had an increased probability of ongoing depression despite higher rates of overall appropriate treatment. Among clients with comorbid substance misuse, the quality improvement programs were associated with improved depression outcomes at 12 months and increased antidepressant use at 6 months. Among clients with no substance misuse, the quality improvement programs improved depression outcomes at 6 months and were associated with increased treatment utilization. CONCLUSIONS Co-occurring substance misuse is associated with depression and with increased risk for poorer depression treatment outcomes under usual care conditions. Quality improvement programs can significantly reduce the likelihood of probable depressive disorders in depressed patients with and without comorbid substance misuse. No consistent evidence was found for a differential program-by-comorbidity effect except for a suggestion of greater increase in psychotherapy among individuals with no substance misuse.

[1]  C. Sherbourne,et al.  Do the Effects of Quality Improvement for Depression Care Differ for Men and Women?: Results of a Group-Level Randomized Controlled Trial , 2004, Medical care.

[2]  J. Foster.  Integrated Treatment for Dual Disorders. A Guide to Effective Practice , 2004 .

[3]  Edward V Nunes,et al.  Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. , 2004, JAMA.

[4]  C. Sherbourne,et al.  Five-year impact of quality improvement for depression: results of a group-level randomized controlled trial. , 2004, Archives of general psychiatry.

[5]  J. Kirchner,et al.  Depressive Disorders and Alcohol Dependence in a Community Population , 2002, Community Mental Health Journal.

[6]  K. Wells,et al.  Improving the care for depression in patients with comorbid medical illness. , 2002, The American journal of psychiatry.

[7]  K. Wells,et al.  Problem substance use among depressed patients in managed primary care. , 2002, Psychosomatics.

[8]  J. Finney,et al.  Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. , 2002, Addiction.

[9]  K. Watkins,et al.  A national survey of care for persons with co-occurring mental and substance use disorders. , 2001, Psychiatric services.

[10]  F. Moeller,et al.  Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. , 2001, Drug and alcohol dependence.

[11]  Richard A. Brown,et al.  Addressing comorbid depressive symptomatology in alcohol treatment. , 2000 .

[12]  I. Katz,et al.  Effects of alcohol consumption on the treatment of depression among elderly patients. , 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[13]  David E. Booth,et al.  Analysis of Incomplete Multivariate Data , 2000, Technometrics.

[14]  F. Nothwehr,et al.  Health-promoting behaviors among adults with type 2 diabetes: findings from the Health and Retirement Study. , 2000, Preventive medicine.

[15]  C. Sherbourne,et al.  Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. , 2000, JAMA.

[16]  K. Wells,et al.  Evidence-based care for depression in managed primary care practices. , 1999, Health affairs.

[17]  P. O'Connor,et al.  Hazardous and harmful alcohol consumption in primary care. , 1999, Archives of internal medicine.

[18]  E L Korn,et al.  Predictive Margins with Survey Data , 1999, Biometrics.

[19]  M. Farrell,et al.  Managing anxiety and depression in alcohol and drug dependence. , 1998, Addictive behaviors.

[20]  David M. Murray,et al.  Design and Analysis of Group- Randomized Trials , 1998 .

[21]  H. Schulberg,et al.  Diagnosis and treatment of depression in primary medical care practice: the application of research findings to clinical practice. , 1998, Journal of clinical psychology.

[22]  N. Jensen,et al.  Meta-analysis of Randomized Control Trials Addressing Brief Interventions in Heavy Alcohol Drinkers , 1997, Journal of General Internal Medicine.

[23]  M. Fava,et al.  Consumption of alcohol, nicotine, and caffeine among depressed outpatients. Relationship with response to treatment. , 1996, Psychosomatics.

[24]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[25]  B. Grant,et al.  Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. , 1995, Drug and alcohol dependence.

[26]  W. Hall,et al.  The AUDIT questionnaire: choosing a cut-off score. Alcohol Use Disorder Identification Test. , 1995, Addiction.

[27]  O. Aasland,et al.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. , 1993, Addiction.

[28]  K. Rost,et al.  Development of Screeners for Depressive Disorders and Substance Disorder History , 1993, Medical care.

[29]  K. Carroll,et al.  One‐Year Follow‐Up Status of Treatment‐Seeking Cocaine Abusers: Psychopathology and Dependence Severity as Predictors of Outcome , 1993, The Journal of nervous and mental disease.

[30]  S. Sacks,et al.  Substance Abuse Treatment for Persons With Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series 42. , 2005 .

[31]  S. Sacks,et al.  Substance Abuse Treatment for Persons With Co-Occurring Disorders , 2005 .

[32]  Daniel F. McCaffrey,et al.  Bias reduction in standard errors for linear regression with multi-stage samples , 2002 .

[33]  K. Wells.  The design of Partners in Care: evaluating the cost-effectiveness of improving care for depression in primary care , 1999, Social Psychiatry and Psychiatric Epidemiology.

[34]  M. Thase,et al.  Fluoxetine versus placebo in depressed alcoholic cocaine abusers. , 1998, Psychopharmacology bulletin.

[35]  B. Grant,et al.  Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. , 1995, Journal of substance abuse.

[36]  J. Brown,et al.  The paradox of guideline implementation: how AHCPR's depression guideline was adapted at Kaiser Permanente Northwest Region. , 1995, The Joint Commission journal on quality improvement.